|
Re: Great surge in PPS for fellow RVX investers
|
3
|
Zenith Epigenetics
|
Jun 19, 2018 04:15PM
|
|
Re: What if
|
3
|
Resverlogix Corp.
|
Mar 07, 2019 11:49AM
|
|
Re: Trading
|
3
|
Zenith Epigenetics
|
Sep 20, 2022 05:13PM
|
|
Re: IF....
|
3
|
Resverlogix Corp.
|
Nov 25, 2015 12:37PM
|
|
Re: 250 MACE scenario question
|
3
|
Resverlogix Corp.
|
Jan 23, 2019 08:10PM
|
|
Re: What impact would a PR like this have?
|
3
|
Resverlogix Corp.
|
Jan 29, 2019 04:17PM
|
|
Re: keep doing PPs at .48/shr with a .50 warrant good till 2025 donny
|
3
|
Resverlogix Corp.
|
May 06, 2022 02:16PM
|
|
Born2Invest Article
|
3
|
BIOASIS TECHNOLOGIES INC
|
Oct 22, 2021 11:37AM
|
|
Re: Need An Explanation
|
3
|
Zenith Epigenetics
|
May 17, 2016 06:26PM
|
|
OTC Expert & Grey Market Restrictions
|
3
|
Zenith Epigenetics
|
Nov 21, 2022 02:08PM
|
|
Re: Zenith trial partners
|
3
|
Zenith Epigenetics
|
Jan 30, 2023 06:05PM
|
|
Re: Not adding up!
|
3
|
Zenith Epigenetics
|
Nov 15, 2021 01:46PM
|
|
Re: Volume
|
3
|
Zenith Epigenetics
|
Apr 13, 2021 09:31AM
|
|
Re: What impact would a PR like this have?
|
3
|
Resverlogix Corp.
|
Jan 29, 2019 05:45PM
|
|
Re: Shot interest jumps big....
|
3
|
Resverlogix Corp.
|
Feb 03, 2017 11:21PM
|
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
3
|
Zenith Epigenetics
|
Jan 27, 2023 02:47PM
|
|
Re: Bioasis Announces Publication of CNS Delivery of siRNA via xB³ ™ Platform Technology
|
3
|
BIOASIS TECHNOLOGIES INC
|
Mar 29, 2021 05:33PM
|
|
Re: https://themarkether...
|
3
|
Resverlogix Corp.
|
Feb 23, 2022 12:47PM
|
|
Re: Meh....beatching is fun
|
3
|
Resverlogix Corp.
|
Aug 05, 2016 05:58PM
|
|
Re: Disagree
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jul 19, 2021 03:17PM
|
